• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 12, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

What are rates of Legionnaires disease among VA patients?

Bioengineer by Bioengineer
June 15, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Bottom Line: Rates of Legionnaires disease (LD) among U.S. Department of Veterans Affairs (VA) patients with overnight stays at a VA facility decreased from 2014 to 2016, even though overall rates of LD among VA patients increased in the same period; 91 percent of the 491 LD cases in the VA surveillance system had no VA exposure or only outpatient VA exposure.

Why The Research Is Interesting: Cases of LD have been increasing in the United States for decades. Health care facilities can transmit Legionella bacteria from building water systems to occupants. The VA has implemented prevention strategies at its medical facilities and has a national reporting system for LD cases, offering the first opportunity to look at LD rates in a U.S. healthcare system on a national level.

What and When: 491 LD cases in the VA surveillance system among patients from 2014 to 2016

What (Study Measures and Outcomes): Annual LD rates with cases categorized as VA or non-VA exposure

How (Study Design): This was an observational study. Researchers were not intervening for purposes of the study and cannot control for all the natural differences that could explain the study results.

Authors: Shantini D. Gamage, Ph.D., M.P.H., of the VA National Infectious Diseases Service, Washington, D.C., and the University of Cincinnati College of Medicine, Cincinnati, Ohio, and coauthors.

Results: Total rates of LD increased from 1.5 to 2.0 per 100,000 VA enrollees from 2014 to 2016; 91 percent of the 491 LD cases had no VA exposure or outpatient-VA exposure; 44 cases of LD occurred in patients who had stayed at the VA overnight. The LD rate for the subset of VA patients who had an overnight stay significantly decreased between 2014 and 2016.

Study Limitations: Some cases of LD may have been missed, including cases in VA enrollees not diagnosed or treated at VA facilities; routine medical record reviews weren't done

Related Material: The invited commentary, "Prevention of Health Care-Associated Legionnaires Disease," by Shawn J. Skerrett, M.D., of the University of Washington School of Medicine, Seattle, also is available on the For The Media website.

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jamanetworkopen.2018.0230)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###

Want to embed a link to this study in your story?: Links will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2018.0230

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. Every Friday, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

Media Contact

Michelle Spivak
[email protected]

@JAMANetworkOpen

Share13Tweet7Share2ShareShareShare1

Related Posts

Mosquito Gene Response Reveals Japanese Encephalitis Entry

September 12, 2025

Poly-L-Histidine-Coated Nanoparticles for Targeted Doxorubicin Delivery

September 11, 2025

Barriers to Video Visits for Non-English Patients

September 11, 2025

Smart ROS Nanoplatform Boosts Targeted Cancer Therapy

September 11, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    64 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Mosquito Gene Response Reveals Japanese Encephalitis Entry

Lumpy Skin Disease: Efficacy of Antibacterial Treatments in Cattle

Poly-L-Histidine-Coated Nanoparticles for Targeted Doxorubicin Delivery

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.